Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

Traverse JH, Henry TD, Vaughan DE, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN)
Am Heart J. 2009 158 (3): 356-63

PMID: 19699857 · PMCID: PMC2784639 · DOI:10.1016/j.ahj.2009.06.009

MeSH Terms (12)

Adult Angioplasty, Balloon, Coronary Bone Marrow Transplantation Double-Blind Method Feasibility Studies Humans Leukocytes, Mononuclear Myocardial Infarction Pilot Projects Research Design Time Factors Treatment Outcome

Connections (2)

This publication is referenced by other Labnodes entities: